Language:

Results 1 - 20 of 69,151 for All Library Resources

Sorted by: Sorted by: Date-newestOr hit Enter to replace sort method

Results 1 2 3 4 5

Show only

Digital Resources/Online E-Resources (52,159)
Peer-reviewed Journals (66,793)

Refined by: subject: Cardiac & Cardiovascular Systems

Result Number	Material Type	Record Details and Options
1	Material Type: Article	Molecular mechanism of triptolide in myocardial fibrosis through the Wnt/β-catenin signaling pathway Scandinavian cardiovascular journal : SCJ, 2024-12, Vol.58 (1), p.2295785 [Peer Reviewed Journal] EISSN: 1651-2006 ;DOI: 10.1080/14017431.2023.2295785 ;PMID: 38164796 Digital Resources/Online E-Resources Services Details Recommendations Reviews Times Cited Citations Cited by
2	Material Type: Article	Assessment of left atrial function by two-dimensional speckle tracking echocardiography in patients with metabolic-associated fatty liver disease The Egyptian heart journal, 2024-12, Vol.76 (1), p.42-42 [Peer Reviewed Journal] The Author(s) 2024 ;2024. The Author(s). ;COPYRIGHT 2024 Springer ;The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1110-2608 ;EISSN: 2090-911X ;DOI: 10.1186/s43044-024-00462-w ;PMID: 38553577 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
3	$Unlocking the potential of sacubitril/valsartan therapy in improving ECG and echocardiographic parameters in heart failure patients with reduced ejection fraction (HErEF)$ $Unlocking the potential of sacubitril/valsartan therapy in improving ECG and echocardiographic parameters in heart failure patients with reduced ejection fraction (HErEF)$ Material Type: Article	Unlocking the potential of sacubitril/valsartan therapy in improving ECG and echocardiographic parameters in heart failure patients with reduced ejection fraction (HErEF) The Egyptian heart journal, 2024-12, Vol.76 (1), p.41-41 [Peer Reviewed Journal] The Author(s) 2024 ;2024. The Author(s). ;COPYRIGHT 2024 Springer ;The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1110-2608 ;EISSN: 2090-911X ;DOI: 10.1186/s43044-024-00468-4 ;PMID: 38546816 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
4	Material Type: Article	Unusual coexistence of restrictive heart disease and Kallmann syndrome: a case report The Egyptian heart journal, 2024-12, Vol.76 (1), p.50-50 [Peer Reviewed Journal] The Author(s) 2024 ;2024. The Author(s). ;COPYRIGHT 2024 Springer ;The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1110-2608 ;EISSN: 2090-911X ;DOI: 10.1186/s43044-024-00479-1 ;PMID: 38635120 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
5	Material Type: Article	Efficacy of inhaled iloprost in children with pulmonary hypertension after pediatric cardiac surgery: a case series Cardiothoracic Surgeon, 2024-12, Vol.32 (1), p.7-7 [Peer Reviewed Journal] The Author(s) 2024 ;COPYRIGHT 2024 Springer ;The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2636-333X ;EISSN: 2662-2203 ;DOI: 10.1186/s43057-024-00125-1 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
6	Material Type: Article	Regulatory bodies and health care systems should systematically evaluate the safety and cost-effectiveness of new cardiovascular treatments in health care registries using prospectively designed protocols Scandinavian cardiovascular journal : SCJ, 2024-12, Vol.58 (1), p.2343383 [Peer Reviewed Journal] EISSN: 1651-2006 ;DOI: 10.1080/14017431.2024.2343383 ;PMID: 38695202 Digital Resources/Online E-Resources Services Details Recommendations Reviews Times Cited Citations Cited by
7	Material Type: Article	Follistatin-like 1 (FSTL1) levels as potential early biomarker of cardiovascular disease in a Mexican population Heart and vessels, 2024-06, Vol.39 (6), p.563-570 [Peer Reviewed Journal] Springer Nature Japan KK, part of Springer Nature 2024. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. ;2024. Springer Nature Japan KK, part of Springer Nature. ;ISSN: 0910-8327 ;EISSN: 1615-2573 ;DOI: 10.1007/s00380-024-02364-y ;PMID: 38381171 Digital Resources/Online E-Resources Services Details Recommendations Reviews Times Cited Citations Cited by
8	Material Type: Article	Impact of pemafibrate on lipid profile and insulin resistance in hypertriglyceridemic patients with coronary artery disease and metabolic syndrome Heart and vessels, 2024-06, Vol.39 (6), p.486-495 [Peer Reviewed Journal] Springer Nature Japan KK, part of Springer Nature 2024. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. ;2024. Springer Nature Japan KK, part of Springer Nature. ;ISSN: 0910-8327 ;EISSN: 1615-2573 ;DOI: 10.1007/s00380-024-02363-z ;PMID: 38393377 Digital Resources/Online E-Resources Services Details Recommendations Reviews Times Cited Citations Cited by
9	Material Type: Article	Survival outcomes of TAVR and self‐expanding versus balloon‐expandable valves in patients with advanced cardiac dysfunction ESC Heart Failure, 2024-06, Vol.11 (3), p.1452-1462 [Peer Reviewed Journal] 2024 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology. ;2024. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2055-5822 ;EISSN: 2055-5822 ;DOI: 10.1002/ehf2.14697 ;PMID: 38318998 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
10	Material Type: Article	Editors' highlight picks from 2023 in ESC heart failure ESC Heart Failure, 2024-06, Vol.11 (3), p.1283-1289 [Peer Reviewed Journal] 2024 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology. ;2024. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2055-5822 ;EISSN: 2055-5822 ;DOI: 10.1002/ehf2.14727 ;PMID: 38409954 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
11	Material Type: Article	Comparison of cardiovascular outcomes of new antihyperglycemic agents in Type 2 Diabetes Mellitus: a meta‐analysis ESC Heart Failure, 2024-06, Vol.11 (3), p.1647-1656 [Peer Reviewed Journal] 2024 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology. ;2024. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2055-5822 ;EISSN: 2055-5822 ;DOI: 10.1002/ehf2.14726 ;PMID: 38419382 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
12	$Sacubitril/valsartan improves all-cause mortality in heart failure patients with reduced ejection fraction and chronic kidney disease$ $Sacubitril/valsartan improves all-cause mortality in heart failure patients with reduced ejection fraction and chronic kidney disease$ Material Type: Article	Sacubitril/valsartan improves all-cause mortality in heart failure patients with reduced ejection fraction and chronic kidney disease Cardiovascular drugs and therapy, 2024-06, Vol.38 (3), p.505-515 [Peer Reviewed Journal] The Author(s) 2023 ;2023. The Author(s). ;The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 0920-3206 ;EISSN: 1573-7241 ;DOI: 10.1007/s10557-022-07421-0 ;PMID: 36609948 Digital Resources/Online E-Resources View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
13	Material Type: Article	Efficacy and Safety of Inclisiran in Patients with Polyvascular Disease: Pooled, Post Hoc Analysis of the ORION-9, ORION-10, and ORION-11 Phase 3 Randomized Controlled Trials Cardiovascular drugs and therapy, 2024-06, Vol.38 (3), p.493-503 [Peer Reviewed Journal] The Author(s) 2022 ;2022. The Author(s). ;The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 0920-3206 ;EISSN: 1573-7241 ;DOI: 10.1007/s10557-022-07413-0 ;PMID: 36550348 Digital Resources/Online E-Resources View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
14	Material Type: Article	Heart failure during acute coronary syndrome and the long‐term cancer risk: the ABC‐9† Study on heart disease ESC Heart Failure, 2024-06, Vol.11 (3), p.1389-1399 [Peer Reviewed Journal] 2024 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology. ;2024. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2055-5822 ;EISSN: 2055-5822 ;DOI: 10.1002/ehf2.14668 ;PMID: 38376007 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
15	Material Type: Article	Use of class IC antiarrhythmic drugs in patients with structural heart disease and implantable cardioverter defibrillator Clinical research in cardiology, 2024-06, Vol.113 (6), p.933-941 [Peer Reviewed Journal] The Author(s) 2024 ;2024. The Author(s). ;The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1861-0684 ;EISSN: 1861-0692 ;DOI: 10.1007/s00392-024-02394-6 ;PMID: 38372753 Digital Resources/Online E-Resources View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
16	Material Type: Article	Sodium glucose cotransporter 2 inhibitors with cardiac arrhythmias in patients with type 2 diabetes mellitus: a systematic review and meta-analysis of randomized placebo-controlled trials Clinical research in cardiology, 2024-06, Vol.113 (6), p.910-923 [Peer Reviewed Journal] The Author(s), under exclusive licence to Springer-Verlag GmbH Germany 2024. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. ;2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany. ;ISSN: 1861-0684 ;EISSN: 1861-0692 ;DOI: 10.1007/s00392-024-02386-6 ;PMID: 38353684 Digital Resources/Online E-Resources Services Details Recommendations Reviews Times Cited Citations Cited by
17	Material Type: Article	Risk calculator for incident atrial fibrillation across a range of prediction horizons The American heart journal, 2024-06, Vol.272, p.1-10 [Peer Reviewed Journal] 2024 The Author(s) ;Copyright © 2024 The Author(s). Published by Elsevier Inc. All rights reserved. ;2024. The Author(s) ;ISSN: 0002-8703 ;EISSN: 1097-6744 ;DOI: 10.1016/j.ahj.2024.03.001 ;PMID: 38458372 Digital Resources/Online E-Resources Services Details Recommendations Reviews Times Cited Citations Cited by
18	Material Type: Article	The Potential Cardiovascular Benefits of COVID-19 Vaccination: Lessons from Influenza and Emerging Evidence Cardiovascular drugs and therapy, 2024-06, Vol.38 (3), p.421-422 [Peer Reviewed Journal] The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2023 ;The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2023. ;ISSN: 0920-3206 ;EISSN: 1573-7241 ;DOI: 10.1007/s10557-023-07485-6 ;PMID: 37421485 Digital Resources/Online E-Resources Services Details Recommendations Reviews Times Cited Citations Cited by
19	Material Type: Article	Novel cardiovascular therapeutics and the risk of financial toxicity Nature reviews cardiology, 2024-06, Vol.21 (6), p.349-350 [Peer Reviewed Journal] Springer Nature Limited 2024. ;ISSN: 1759-5002 ;EISSN: 1759-5010 ;DOI: 10.1038/s41569-024-01010-4 ;PMID: 38485769 Digital Resources/Online E-Resources Services Details Recommendations Reviews Times Cited Citations Cited by
20	$Low‐density lipoprotein cholesterol, erythrocyte, and platelet in heart failure with preserved ejection fraction$ $Low‐density lipoprotein cholesterol, erythrocyte, and platelet in heart failure with preserved ejection fraction$ Material Type: Article	Low‐density lipoprotein cholesterol, erythrocyte, and platelet in heart failure with preserved ejection fraction ESC Heart Failure, 2024-06, Vol.11 (3), p.1758-1766 [Peer Reviewed Journal] 2024 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology. ;2024. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2055-5822 ;EISSN: 2055-5822 ;DOI: 10.1002/ehf2.14734 ;PMID: 38454876 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by